These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17141276)

  • 1. The involvement of phosphatidylinositol 3-kinase /Akt signaling in high glucose-induced downregulation of GLUT-1 expression in ARPE cells.
    Kim DI; Lim SK; Park MJ; Han HJ; Kim GY; Park SH
    Life Sci; 2007 Jan; 80(7):626-32. PubMed ID: 17141276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin-induced VEGF receptor and calcium channel transactivation stimulate GLUT-1 synthesis and trafficking through PPARγ and TC10 in mouse embryonic stem cells.
    Suh HN; Han HJ
    Stem Cell Res; 2013 May; 10(3):371-86. PubMed ID: 23455393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 upregulates glucose transporter-1 expression level via protein kinase C, phosphoinositol-3 kinase, and mammalian target of rapamycin pathways in mouse embryonic stem cells.
    Lee MY; Han HJ
    Int J Biochem Cell Biol; 2008; 40(11):2421-30. PubMed ID: 18479958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
    Yamane K; Ihn H; Tamaki K
    Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C.
    Tenzer A; Zingg D; Rocha S; Hemmings B; Fabbro D; Glanzmann C; Schubiger PA; Bodis S; Pruschy M
    Cancer Res; 2001 Nov; 61(22):8203-10. PubMed ID: 11719451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo.
    Luo XM; Xu B; Zhou ML; Bao YY; Zhou SH; Fan J; Lu ZJ
    PLoS One; 2015; 10(11):e0143306. PubMed ID: 26600164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidant-mediated Akt activation in human RPE cells.
    Yang P; Peairs JJ; Tano R; Jaffe GJ
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4598-606. PubMed ID: 17003457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
    Hemström TH; Sandström M; Zhivotovsky B
    Int J Cancer; 2006 Sep; 119(5):1028-38. PubMed ID: 16570272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation.
    Samih N; Hovsepian S; Aouani A; Lombardo D; Fayet G
    Endocrinology; 2000 Nov; 141(11):4146-55. PubMed ID: 11089547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
    Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K
    Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
    Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
    J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE.
    Wang L; Chen Y; Sternberg P; Cai J
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1671-8. PubMed ID: 18385090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
    Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
    Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].
    Yu P; Yu DM; Qi JC; Wang J; Zhang QM; Zhang JY; Tang YZ; Xing QL; Li MZ
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3425-30. PubMed ID: 17313857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
    Chi TC; Chen WP; Chi TL; Kuo TF; Lee SS; Cheng JT; Su MJ
    Life Sci; 2007 Apr; 80(18):1713-20. PubMed ID: 17346750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose-induced inhibition of 2-deoxyglucose uptake is mediated by cAMP, protein kinase C, oxidative stress and mitogen-activated protein kinases in mouse embryonic stem cells.
    Han HJ; Heo JS; Lee YJ; Min JJ; Park KS
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):211-20. PubMed ID: 16487264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of phosphatidylinositol 3-kinase and Akt signalling pathway by PKC.
    Wen HC; Huang WC; Ali A; Woodgett JR; Lin WW
    Cell Signal; 2003 Jan; 15(1):37-45. PubMed ID: 12401518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.